Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.

Yanada M, Mori J, Aoki J, Masuko M, Harada K, Uchida N, Doki N, Fukuda T, Sakura T, Kanamori H, Sawa M, Kondo T, Katayama Y, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Ann Hematol. 2019 Jun 15. doi: 10.1007/s00277-019-03736-5. [Epub ahead of print]

PMID:
31203422
2.

BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T, Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M.

Blood Adv. 2019 Jun 11;3(11):1750-1760. doi: 10.1182/bloodadvances.2019000077.

3.

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis.

Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study; Group for Cell Therapy (KSGCT).

Leukemia. 2019 May 30. doi: 10.1038/s41375-019-0494-9. [Epub ahead of print]

PMID:
31147621
4.

Guest Editorial: Are "alternative" stem cell sources still alternative in the new era?

Kanda J.

Int J Hematol. 2019 Jul;110(1):20-21. doi: 10.1007/s12185-019-02671-5. Epub 2019 May 28. No abstract available.

PMID:
31140118
5.

Examination of the Catabolic Rates of 13C-Labeled Fatty Acids Bound to the α and β Positions of Triacylglycerol Using 13CO2 Expired from Mice.

Yoshinaga K, Beppu F, Yamatani Y, Kubo A, Yoshinaga-Kiriake A, Nagai T, Yoshida A, Kanda J, Gotoh N.

J Oleo Sci. 2019 Jun 6;68(6):591-598. doi: 10.5650/jos.ess19012. Epub 2019 May 16.

6.

Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience.

Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S.

Bone Marrow Transplant. 2019 May 8. doi: 10.1038/s41409-019-0539-8. [Epub ahead of print]

PMID:
31068659
7.

Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease.

Hayakawa N, Kodera S, Ohki N, Kanda J.

Heart Vessels. 2019 Apr 15. doi: 10.1007/s00380-019-01412-2. [Epub ahead of print]

PMID:
30989328
8.

Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study.

Sonoura T, Kodera S, Shakya S, Kanda J.

J Cardiol. 2019 Apr 11. pii: S0914-5087(19)30078-4. doi: 10.1016/j.jjcc.2019.03.007. [Epub ahead of print]

PMID:
30982679
9.

Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.

Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K.

Br J Haematol. 2019 Apr 2. doi: 10.1111/bjh.15898. [Epub ahead of print]

PMID:
30941758
10.

Mechanisms of radiocesium depuration in Sebastes cheni derived by simulation analysis of measured 137Cs concentrations off southern Fukushima 2014-2016.

Ishimaru T, Tateda Y, Tsumune D, Aoyama M, Hamajima Y, Kasamatsu N, Yamada M, Yoshimura T, Mizuno T, Kanda J.

J Environ Radioact. 2019 Jul;203:200-209. doi: 10.1016/j.jenvrad.2019.03.012. Epub 2019 Mar 27.

PMID:
30927563
11.

Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.

Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Int J Hematol. 2019 Jun;109(6):684-693. doi: 10.1007/s12185-019-02631-z. Epub 2019 Mar 15.

PMID:
30877606
12.

ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.

Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y; donor/source working group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Mar 13. doi: 10.1038/s41409-019-0496-2. [Epub ahead of print]

PMID:
30867557
13.

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 May;94(5):E143-E146. doi: 10.1002/ajh.25438. Epub 2019 Mar 6. No abstract available.

PMID:
30773707
14.

Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jan 22. doi: 10.1038/s41409-019-0434-3. [Epub ahead of print]

PMID:
30670824
15.

Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation.

Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A.

Transpl Infect Dis. 2019 Apr;21(2):e13049. doi: 10.1111/tid.13049. Epub 2019 Feb 6.

PMID:
30656802
16.

Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.

Iwasaki M, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A.

BMC Infect Dis. 2019 Jan 9;19(1):38. doi: 10.1186/s12879-018-3665-9.

17.

Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin.

Kako S, Gomyo A, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda J, Kanda Y.

Eur J Haematol. 2019 Mar;102(3):256-264. doi: 10.1111/ejh.13204. Epub 2019 Jan 9.

PMID:
30578673
18.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

19.

Endovascular Therapy Using Diluted Contrast Medium for Critical Limb Ischemia in a Patient with Chronic Kidney Disease.

Hayakawa N, Kodera S, Ohki N, Kushida S, Morita H, Kanda J, Komuro I.

Int Heart J. 2019 Jan 25;60(1):226-230. doi: 10.1536/ihj.18-125. Epub 2018 Nov 20.

20.

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Leuk Lymphoma. 2019 Jun;60(6):1493-1502. doi: 10.1080/10428194.2018.1535115. Epub 2018 Nov 20.

PMID:
30457400
21.

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R.

Int J Hematol. 2019 Feb;109(2):175-186. doi: 10.1007/s12185-018-2560-x. Epub 2018 Nov 14.

PMID:
30430419
22.

Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease.

Nishi K, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2178-2183. doi: 10.1016/j.bbmt.2018.06.031. Epub 2018 Jul 3.

PMID:
30417828
23.

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2018 Nov 6. doi: 10.1038/s41409-018-0369-0. [Epub ahead of print]

PMID:
30401965
24.

Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Jan;94(1):103-110. doi: 10.1002/ajh.25336. Epub 2018 Nov 29.

PMID:
30370944
25.

Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation.

Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2019 Mar;25(3):587-593. doi: 10.1016/j.bbmt.2018.10.014. Epub 2018 Oct 22.

PMID:
30359733
26.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Blood Adv. 2018 Oct 23;2(20):2744-2754. doi: 10.1182/bloodadvances.2018020305.

27.

Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.

Atsuta Y, Kato S, Morishima Y, Ohashi K, Fukuda T, Ozawa Y, Eto T, Iwato K, Uchida N, Ota S, Onizuka M, Ichinohe T, Kanda J, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Mar;25(3):436-442. doi: 10.1016/j.bbmt.2018.10.002. Epub 2018 Oct 8.

PMID:
30308326
28.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2019 Feb;25(2):270-278. doi: 10.1016/j.bbmt.2018.09.004. Epub 2018 Oct 3.

PMID:
30292009
29.

Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.

Iemura T, Itoh M, Mano C, Oba A, Kawabata N, Horisawa Y, Matsui M, Miyahara Y, Kanda J.

Transfusion. 2018 Dec;58(12):2773-2776. doi: 10.1111/trf.14885. Epub 2018 Sep 28.

PMID:
30265752
30.

Evaluation of a Novel Classification of Heat-Related Illnesses: A Multicentre Observational Study (Heat Stroke STUDY 2012).

Yamamoto T, Fujita M, Oda Y, Todani M, Hifumi T, Kondo Y, Shimazaki J, Shiraishi S, Hayashida K, Yokobori S, Takauji S, Wakasugi M, Nakamura S, Kanda J, Yagi M, Moriya T, Kawahara T, Tonouchi M, Yokota H, Miyake Y, Shimizu K, Tsuruta R.

Int J Environ Res Public Health. 2018 Sep 8;15(9). pii: E1962. doi: 10.3390/ijerph15091962.

31.

[Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].

Muneoka K, Shirai Y, Sasaki M, Honma S, Sakata J, Kanda J, Wakabayashi H, Wakai T, Miyazaki M.

Gan To Kagaku Ryoho. 2018 Aug;45(8):1159-1163. Japanese.

PMID:
30158411
32.

An Autopsy Case of Familial Neuronal Intranuclear Inclusion Disease with Dementia and Neuropathy.

Yamaguchi N, Mano T, Ohtomo R, Ishiura H, Almansour MA, Mori H, Kanda J, Shirota Y, Taira K, Morikawa T, Ikemura M, Yanagi Y, Murayama S, Shimizu J, Sakurai Y, Tsuji S, Iwata A.

Intern Med. 2018 Dec 1;57(23):3459-3462. doi: 10.2169/internalmedicine.1141-18. Epub 2018 Aug 10.

33.

Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats.

Kanda J, Izumo N, Furukawa M, Shimakura T, Yamamoto N, E Takahashi H, Asakura T, Wakabayashi H.

Biomed Res. 2018;39(3):131-139. doi: 10.2220/biomedres.39.131.

34.

Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.

Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R.

Transfus Med Rev. 2018 Jun 1. pii: S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. [Epub ahead of print] Review.

35.

Radioactive cesium concentrations in coastal suspended matter after the Fukushima nuclear accident.

Kubo A, Tanabe K, Suzuki G, Ito Y, Ishimaru T, Kasamatsu-Takasawa N, Tsumune D, Mizuno T, Watanabe YW, Arakawa H, Kanda J.

Mar Pollut Bull. 2018 Jun;131(Pt A):341-346. doi: 10.1016/j.marpolbul.2018.04.042. Epub 2018 May 7.

PMID:
29886956
36.

Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).

Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Br J Haematol. 2018 Jul;182(2):245-250. doi: 10.1111/bjh.15399. Epub 2018 May 29.

PMID:
29808919
37.

Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.

Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, Yoshida N, Watanabe K, Shimada H, Inagaki J, Koh K, Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Okada K, Inoue M, Hashii Y, Teshima T, Murata M, Atsuta Y.

Bone Marrow Transplant. 2019 Jan;54(1):68-75. doi: 10.1038/s41409-018-0221-6. Epub 2018 May 24.

PMID:
29795428
38.

Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data.

Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1596-1601. doi: 10.1016/j.bbmt.2018.03.009. Epub 2018 Mar 15.

PMID:
29551446
39.

Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.

Ishiura H, Doi K, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, Toyoshima Y, Kakita A, Takahashi H, Suzuki Y, Sugano S, Qu W, Ichikawa K, Yurino H, Higasa K, Shibata S, Mitsue A, Tanaka M, Ichikawa Y, Takahashi Y, Date H, Matsukawa T, Kanda J, Nakamoto FK, Higashihara M, Abe K, Koike R, Sasagawa M, Kuroha Y, Hasegawa N, Kanesawa N, Kondo T, Hitomi T, Tada M, Takano H, Saito Y, Sanpei K, Onodera O, Nishizawa M, Nakamura M, Yasuda T, Sakiyama Y, Otsuka M, Ueki A, Kaida KI, Shimizu J, Hanajima R, Hayashi T, Terao Y, Inomata-Terada S, Hamada M, Shirota Y, Kubota A, Ugawa Y, Koh K, Takiyama Y, Ohsawa-Yoshida N, Ishiura S, Yamasaki R, Tamaoka A, Akiyama H, Otsuki T, Sano A, Ikeda A, Goto J, Morishita S, Tsuji S.

Nat Genet. 2018 Apr;50(4):581-590. doi: 10.1038/s41588-018-0067-2. Epub 2018 Mar 5.

PMID:
29507423
40.

[Impact of HLA mismatch on transplant outcomes].

Kanda J.

Rinsho Ketsueki. 2017;58(12):2415-2424. doi: 10.11406/rinketsu.58.2415. Japanese.

PMID:
29332878
41.

Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Int J Hematol. 2018 May;107(5):578-585. doi: 10.1007/s12185-017-2396-9. Epub 2018 Jan 5.

PMID:
29305770
42.

Prognostic significance of disseminated intravascular coagulation in patients with heat stroke in a nationwide registry.

Hifumi T, Kondo Y, Shimazaki J, Oda Y, Shiraishi S, Wakasugi M, Kanda J, Moriya T, Yagi M, Ono M, Kawahara T, Tonouchi M, Yokota H, Miyake Y, Shimizu K.

J Crit Care. 2018 Apr;44:306-311. doi: 10.1016/j.jcrc.2017.12.003. Epub 2017 Dec 9.

PMID:
29253838
43.

Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Apr;24(4):717-725. doi: 10.1016/j.bbmt.2017.11.029. Epub 2017 Dec 27.

44.

[The Changes in the Neutrophil-to-Lymphocyte Ratio Can Predict the Timing of Chemotherapeutic Regimen Alteration in Patients with Metastatic Colorectal Cancer].

Muneoka K, Shirai Y, Sasaki M, Honma S, Sakata J, Kanda J, Wakabayashi H, Wakai T.

Gan To Kagaku Ryoho. 2017 Nov;44(11):1001-1005. Japanese.

PMID:
29138376
45.

Effects of the Antiepileptic Drugs Phenytoin, Gabapentin, and Levetiracetam on Bone Strength, Bone Mass, and Bone Turnover in Rats.

Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, Takahashi HE, Wakabayashi H.

Biol Pharm Bull. 2017;40(11):1934-1940. doi: 10.1248/bpb.b17-00482.

46.

Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.

Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Tanihara A, Nishida J, Kanda Y.

Hematology. 2018 Jun;23(5):271-276. doi: 10.1080/10245332.2017.1396026. Epub 2017 Oct 31.

PMID:
29086660
47.

Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats.

Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, E Takahashi H, Wakabayashi H.

Biomed Res. 2017;38(5):297-305. doi: 10.2220/biomedres.38.297.

48.

Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.

Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda Y.

Ann Hematol. 2018 Jan;97(1):169-179. doi: 10.1007/s00277-017-3141-4. Epub 2017 Sep 30.

PMID:
28965134
49.

Effect of the antidiabetic agent pioglitazone on bone metabolism in rats.

Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, Takahashi HE, Wakabayashi H.

J Pharmacol Sci. 2017 Sep;135(1):22-28. doi: 10.1016/j.jphs.2017.08.004. Epub 2017 Aug 26.

50.

D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.

Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Fukunaga K, Wakita S, Ryotokuji T, Fukuda T, Inokuchi K.

Ann Hematol. 2017 Oct;96(10):1641-1652. doi: 10.1007/s00277-017-3074-y. Epub 2017 Jul 31.

PMID:
28762080

Supplemental Content

Support Center